期刊文献+

MMP-2和VEGF-C在甲状腺乳头状癌中的表达及临床意义 被引量:10

Expressions and Clinical Significance of MMP-2 and VEGF-C in Papillary Thyroid Carcinoma
下载PDF
导出
摘要 目的探讨甲状腺乳头状癌中基质金属蛋白酶-2(MMP-2)和血管内皮细胞生长因子-C(VEGF-C)的表达及其临床意义。方法应用免疫组织化学SP法检测78例甲状腺乳头状癌和同期18例甲状腺良性肿瘤组织中MMP-2和VEGF-C的表达情况,并进行比较分析。结果MMP-2和VEGF-C在甲状腺乳头状癌组织中的表达阳性率(80.77%和75.64%)明显高于甲状腺良性肿瘤(11.11%和22.22%),P<0.05。MMP-2和VEGF-C的表达与甲状腺乳头状癌的浸润程度和颈淋巴结转移有关,即肿瘤浸润达包膜至包膜外者或临床有颈淋巴结转移者,其表达阳性率明显高于肿瘤浸润局限在包膜内者或临床无颈淋巴结转移者(P<0.05);同时临床无颈淋巴结转移的41例患者在术后随访中,出现颈淋巴结转移者其表达阳性率亦明显高于未出现转移者(P<0.05)。MMP-2和VEGF-C在甲状腺乳头状癌组织中的表达呈正相关(Gamma=0.846,P<0.05)。结论MMP-2和VEGF-C对甲状腺良、恶性肿瘤的鉴别有一定帮助;MMP-2和VEGF-C可以作为预测甲状腺乳头状癌浸润转移的分子生物学指标之一;两者具有协同作用,联合检测对预测颈淋巴结转移状况有一定的指导意义。 Objective To study the expressions and clinical significance of matrix metalloproteinases-2 (MMP 2) and vascular endothelial growth facto-C (VEGF C) in patients with papillary thyroid carcinoma (PTC). Methods SP immunohistochemical technique was used to detect the expressions of MMP-2 and VEGF-C in 78 cases of PTC and 18 cases of thyroid benign tumors. Results The positive expression rates of MMP-2 and VEGF-C in PTC (80.77 %, 75.64 % ) were significantly higher than those of the thyroid benign tumor ( 11.11%, 22.22 % ), P〈0. 05. The expressions of MMP-2 and VEGF-C were correlated to the degree of infiltration and lymph node metastasis in PTC: In those which infiltrated to or over the thyroid capsular, or had clinical neck lymph node metasta sis, the positive expression rates were significantly higher than those in the other cases which had confined invasion of thyroid capsular or non clinical metastasis of neck lymph node (P〈0.05). And during the follow up of 41 patients who didn't have clinical neck lymph node metastasis before operation, the positive expression rates of those who had clinical neck lymph node metastasis were significantly higher than those in the other patients who didn't have neck lymph node metastasis (P〈0.05). There was significantly positive correlation between the expressions of MMP 2 and VEGF-C in PTC (Gamma=0. 846, P〈0.05). Conclusions MMP-2 and VEGF-C may be used to distinguish malignant and benign thyroid tumor; The expressions of MMP-2 and VEGF-C are correlated with the degree of infiltration and neck lymph node metastasis in PTC; Combined detection of MMP2 and VEGF-C will be more accurate to predict condition of lymph node metastasis.
出处 《中国普外基础与临床杂志》 CAS 2009年第11期906-910,共5页 Chinese Journal of Bases and Clinics In General Surgery
关键词 甲状腺乳头状癌 免疫组织化学 基质金属蛋白酶-2 血管内皮细胞生长因子-C Papillary thyroid carcinoma Immunohistoehemistry Matrix metalloproteinases-2 Vascular endothelial growth faetor-C
  • 相关文献

参考文献25

  • 1王东升,钱向龙,张浩.对cN_0甲状腺乳头状癌行中央区淋巴结清扫的临床意义[J].山东医药,2007,47(21):79-80. 被引量:2
  • 2Leboulleux S, Rubino C, Baudin E, et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis [J]. J Clin Endocrinol Metab, 2005; 90(10): 5723-5729.
  • 3Neuchrist C, Erovic BM, HandisuryaA, et al. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck [J]. Head Neck, 2003, 25(6): 464-474.
  • 4Ishikawa M, Kitayama J, Kazama S, et al. Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma [J]. Jpn J Clin Oncol, 2003; 33(1): 21-27.
  • 5Lymboussaki A, Olofsson B, Eriksson U, et al. Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differen tiated adult endothelia [J]. Circ Res, 1999, 85(11) : 992-999.
  • 6Itoh Y, Ito N, Nagase H, et al. Cell surface collagenolysis requires homodimerization of the membrane-bound collagenase MT1-MMP [J]. Mol Biol Cell, 2006, 17(12): 5390-5399.
  • 7王伟,尹家俊,路小光,姜志良,姚永强,赵晖.MMP-2和CD44v6蛋白表达与胃癌生物学行为相关性的实验研究[J].中国肿瘤临床与康复,2005,12(6):502-506. 被引量:5
  • 8Cai M, Onoda K, Takao M, et al. Degradation of tenascin-C and activity of matrix metalloproteinase 2 are associated with tumor recurrence in early stage non small cell lung cancer [J]. Clin Cancer Res, 2002, 8(4): 1152-1156.
  • 9Maruyama S, Kawata R, Shimada T, et al. Study of matrix metalloproteinase-2 and 9 in thyroid papillary cancer [J]. Nippon Jibiinkoka Gakkai Kaiho, 20003 103(5): 499-505.
  • 10Baldini E, Toller M, Graziano FM, et al. Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines [J]. Thyroid, 2004; 14(11) : 881-888.

二级参考文献42

  • 1朱永学,王弘士,吴毅,嵇庆海,黄彩萍.甲状腺乳头状癌Ⅵ区淋巴结的归属[J].中华外科杂志,2004,42(14):867-869. 被引量:112
  • 2孙向东,杨秀荣.甲状腺乳头状癌经淋巴结转移规律及治疗策略[J].河南肿瘤学杂志,2004,17(5):336-337. 被引量:21
  • 3陈福进,李秋梨,曾宗渊,宋明,杨安奎,张诠.分化型甲状腺癌的治疗及影响复发的因素分析[J].癌症,2004,23(11):1311-1316. 被引量:50
  • 4景纯,温玉明,王大章,王昌美.口腔颊、舌鳞癌癌周淋巴管形态学特征与颈淋巴结转移[J].华西口腔医学杂志,1995,13(2):130-134. 被引量:26
  • 5Brooks JR,Starnes HF,Brooks DC,et al.Surgical therapy for thyroid carcinoma:A review of 1249 solitary thyroid nodules.Surgery,1988,104(6):940-946
  • 6Flynn MB,lyons KJ,Tarter JW,et al.Local complications after surgical resection for thyroid carcinoma.Am J Surg,1994,168(5):404-407
  • 7Rossi RL,Cady B,Silverman MI,et al.Current results of conservative surgery for differentiated thyroid carcinoma.World J Surg,1986,10(4):612-622
  • 8Cady B.Argument against total thyroidectomy.Probl General Surg,1997,14:44-48
  • 9Hay ID,Grant CS,Bergstralh EJ,et al.Unilateral total lobectomy:Is it surfficient surgical treatment for patient with AMES low-risk papillary thyroid carcinoma? Surgery,1998,124(6):958-964
  • 10Hay ID,Grant CS,Taylor WF,et al.Ipsilateral lobectory versus bilateral lobar resection in papillary thyroid carcinoma:A retrospective analysis of surgical outcome using a novel prognostic scoring system.Surgery,1987,102(6):1088-1095

共引文献62

同被引文献105

  • 1刘东方,邓华聪,许改平,雄波,侯平.人甲状腺原代细胞的长期培养[J].中华内分泌代谢杂志,2005,21(2):181-183. 被引量:11
  • 2莫祥兰,黄振录,周祥祯,丁志敏,韦荣干,王国刚.高分子量角蛋白和TPO在甲状腺乳头状癌诊断中的价值[J].中国实验诊断学,2006,10(6):585-587. 被引量:2
  • 3Tian-Bao Wang,Mei-hai Deng,Wan-Shou Qiu,Wen-Guang Dong.Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer[J].World Journal of Gastroenterology,2007,13(12):1794-1798. 被引量:17
  • 4Maatta M,Soini Y,Liakka A,et al.Differential expression of matrix metalloproteinase(MMP)-2,MMP-9,and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma;implications for tumor progression and clinical prognosis[J].Clin Cancer Res,2000;6(7):2726-2734.
  • 5Yamamoto H.Itoh F,Adachi Y,et al.Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma[J].Gastroenterology,1997;112(4):1290-1296.
  • 6Rossello A,Nuti E,Orlandini E,et al.New N-arylsulfonyl-N-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A(MMP-2)[J].Bioorg Med Chem,2004; 12(9):2441-2450.
  • 7Levitt NC,Eskens FA,O'Byrne KJ,et al.Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor,MMI270(CGS27023A),in patients with advanced solid cancer[J].Clin Cancer Res,2001;7(7):1912-1922.
  • 8Li YL,Xu WF.Design,synthesis,and activity of caffeoyl pyrrolidine derivatives as potential gelatinase inhibitors[J].Bioorg Med Chem,2004;12(19);5171-5180.
  • 9Li X,Li Y,Xu W.Design,synthesis,and evaluation of novel galloyl pyrrolidine derivatives as potential anti-tumor agents[J].Bioorg Med Chem,2006;14(5):1287-1293.
  • 10Qu XJ,Yuan YX,Tian ZG,et al.Using caffeoyl pyrrolidine derivative LY52,a potential inhibitor of matrix metalloproteinase-2,to suppress tumor invasion and metastasis[J].Int J Mol Med,2006;18(4):609-614.

引证文献10

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部